kabutan

TAIKO PHARMA, First Half Ordinary Profit Decreases by 96%, Apr-Jun Ordinary Profit Decreases by 97%

Fri Aug 8, 2025 3:30 pm JST Earnings

4574 TAIKO PHARMACEUTICAL CO., LTD. 【J-GAAP】

Earnings Report

TAIKO PHARMACEUTICAL CO., LTD. <4574> [TSE Prime] announced its financial results after the market closed on August 8th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2025 (January to June) significantly dropped 96.2% from the same period last year to 20 million yen. Progress toward the full-year plan of 200 million yen was 10.0%, also falling below the same period of the previous year of 76.7%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to December period (second half) is expected to grow 12.5% from the same period last year, reaching 180 million yen.

In the most recent three-month period, from April to June (2Q), the consolidated ordinary profit significantly dropped to 9 million yen, a 97.0% decrease compared to the same period last year. The operating profit margin sharply declined from 18.1% in the same period last year to 0.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 2,488 -396 -510 -514 -11.4 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 2,860 482 528 764 15.2 76.7 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 2,412 46 20 279 5.6 10.0 Aug 8, 2025 J-GAAP
YoY -15.7% -90.5% -96.2% -63.5% -63.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － － Feb 13, 2025 J-GAAP
Jan - Jun, 2025 Results 2,412 46 20 279 5.6 0 Aug 8, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 3,432 147 160 134 2.7 0 Feb 13, 2025 J-GAAP
Jul - Dec, 2025 Guidance 3,888 169 180 21 0.4 － Aug 8, 2025 J-GAAP
YoY +13.3% +15.0% +12.5% -84.3% -84.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 6,292 629 688 898 17.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance 6,300 215 200 300 6.0 － Feb 13, 2025 J-GAAP
YoY +0.1% -65.8% -70.9% -66.6% -66.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 1,483 268 299 292 5.8 18.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 1,719 244 177 -50 -1.0 14.2 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 1,713 -97 -17 184 3.7 -5.7 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 1,150 44 11 292 5.8 3.8 May 9, 2025 J-GAAP
Apr - Jun, 2025 1,262 2 9 -13 -0.3 0.2 Aug 8, 2025 J-GAAP
YoY -14.9% -99.3% -97.0% － －

Related Articles